Table of Content

1 Market Overview

• 1.1 Market Segment Overview
  • 1.1.1 Product Definition
  • 1.1.2 Market by Type
    • 1.1.2.1 F-627
    • 1.1.2.2 BBT-018
    • 1.1.2.3 Filgrastim
    • 1.1.2.4 GW-003
    • 1.1.2.5 NLA-101
    • 1.1.2.6 Others
  • 1.1.3 Market by Application
    • 1.1.3.1 Hospital
    • 1.1.3.2 Clinic
    • 1.1.3.3 Others
• 1.2 Global and China Market Size
  • 1.2.1 Global Overview
  • 1.2.2 China Overview

2 Global and China Market by Company

• 2.1 Global
  • 2.1.1 Global Sales by Company
  • 2.1.2 Global Price by Company
• 2.2 China
  • 2.2.1 China Sales by Company
  • 2.2.2 China Price by Company

3 Global and China Market by Type

• 3.1 Global
  • 3.1.1 Global Sales by Type
  • 3.1.2 Global Price by Type
• 3.2 China
  • 3.2.1 China Sales by Type
  • 3.2.2 China Price by Type

4 Global and China Market by Application

• 4.1 Global
  • 4.1.1 Global Sales by Application
  • 4.1.2 Global Price by Application
• 4.2 China
  • 4.2.1 China Sales by Application
  • 4.2.2 China Price by Application

5 China Trade

• 5.1 Export
• 5.2 Import

6 Key Manufacturers

• 6.1 BeyondSpring Pharmaceuticals Inc
  • 6.1.1 Company Information
  • 6.1.2 Product Specifications
  • 6.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
• 6.2 Biocon Ltd
• 6.3 Bolder Biotechnology Inc
• 6.4 Cellerant Therapeutics Inc
• 6.5 Chong Kun Dang Pharmaceutical Corp
• 6.6 Cinfa Biotech SL
• 6.7 Dr. Reddy's Laboratories Ltd
• 6.8 Gene Techno Science Co Ltd
• 6.9 Generon (Shanghai) Corp Ltd
• 6.10 Genexine Inc
• 6.11 GlycoMimetics Inc
• 6.12 Hanmi Pharmaceuticals Co Ltd
• 6.13 Intas Pharmaceuticals Ltd
• 6.14 Lupin Ltd
• 6.15 Mycenax Biotech Inc
• 6.16 Myelo Therapeutics GmbH
• 6.17 Nohla Therapeutics Inc
• 6.18 Octapharma AG
• 6.19 Pangen Biotech Inc.
• 6.20 Pfenex Inc
• 6.21 Pfizer Inc
• 6.22 Reliance Life Sciences Pvt Ltd
• 6.23 Richter Gedeon Nyrt
• 6.24 Sandoz International GmbH
• 6.25 USV Pvt Ltd

7 Industry Upstream

• 7.1 Industry Chain
• 7.2 Raw Materials

8 Market Environment

• 8.1 SWOT
• 8.2 Porter's Five Forces

9 Conclusion

Summary

Market Segment as follows:
By Type
F-627
BBT-018
Filgrastim
GW-003
NLA-101
Others
By Application
Hospital
Clinic
Others
By Company
BeyondSpring Pharmaceuticals Inc
Biocon Ltd
Bolder Biotechnology Inc
Cellerant Therapeutics Inc
Chong Kun Dang Pharmaceutical Corp
Cinfa Biotech SL
Dr. Reddy's Laboratories Ltd
Gene Techno Science Co Ltd
Generon (Shanghai) Corp Ltd
Genexine Inc
GlycoMimetics Inc
Hanmi Pharmaceuticals Co Ltd
Intas Pharmaceuticals Ltd
Lupin Ltd
Mycenax Biotech Inc
Myelo Therapeutics GmbH
Nohla Therapeutics Inc
Octapharma AG
Pangen Biotech Inc.
Pfenex Inc
Pfizer Inc
Reliance Life Sciences Pvt Ltd
Richter Gedeon Nyrt
Sandoz International GmbH
USV Pvt Ltd
The main contents of the report including:
Section 1:
Product definition, type and application, global and China market overview;
Section 2:
Global and China Market competition by company;
Section 3:
Global and China sales revenue, volume and price by type;
Section 4:
Global and China sales revenue, volume and price by application;
Section 5:
China export and import;
Section 6:
Company information, business overview, sales data and product specifications;
Section 7:
Industry chain and raw materials;
Section 8:
SWOT and Porter's Five Forces;
Section 9:
Conclusion.